Atlas Trials

BKM120 as Second-line Therapy for Advanced Endometrial Cancer

Clinical trial NCT01289041 · COMPLETED

Trial details

NCT number
NCT01289041
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Endometrial Cancer
Start date
2011-02-01
Primary completion
2014-03-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.